# A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair

> **NCT00528970** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 374 (actual)

## Conditions studied

- Ileus

## Interventions

- **DRUG:** MOA-728
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00528970
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-17
- **Primary completion:** 2008-02-05
- **Final completion:** 2008-02-05
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2019-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528970, "A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00528970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*